Rodgers, Z.J., Bejmert, K., Chung, T., Furness, J., Abery, P., Kemp‐Smith, K., Taylor, N., Bruce, K.C. and Snelling, P.J., 2024. Evaluating the effectiveness of arterial pressure point techniques as a first aid method for external haemorrhage control: A systematic review. Emergency Medicine Australasia.
Mitra, B., Wake, E., Talarico, C., Czuchwicki, S., Koolstra, C., Campbell, D., Hendel, S. and Winearls, J., 2024. Resuscitation of adult shocked trauma patients using major haemorrhage protocol guided by viscoelastic haemostatic assays versus formulaic approach. Transfusion Medicine, 34(6), pp.514-519.
Dale, K., Winkleman, C., Hughes, I., Heathcote, K. and Wake, E., 2024. Health related outcomes of patients with serious traumatic injury: Results of a longitudinal follow-up program delivered by trauma clinicians. Injury, 55(12), p.112012.
George, S., Wake, E., Jansen, M., Soundappan, S., Ellis, D., Blanch, A., Gibbons, K. and Winearls, J., 2024. PP031 Topic: AS03–Disaster Medicine/Trauma, Triage and Transport/Mass Critical Care/Pandemics/Medicine in War Zones/Other: Fibrinogen early in severe paediatric trauma study (FIESTY JUNIOR): A randomised clinical trial. Pediatric Critical Care Medicine, 25(11S), p.e30.
Simpson, J., McCullough, J., Walters, K., Wake, E., Ho, D., Chan, E., Campbell, D. and Winearls, J., 2023. Rotational thromboelastometry values across age groups in all trauma patients presenting to a level 1 trauma centre: An observational study. Emergency Medicine Australasia.
Mohtady Ali, H., Ranse, J., Roiko, A. and Desha, C., 2023. Enabling transformational leadership to foster disaster-resilient hospitals. International journal of environmental research and public health, 20(3), p.2022.
Morrow, G.B., Feller, T., McQuilten, Z., Wake, E., Ariëns, R.A., Winearls, J., Mutch, N.J., Laffan, M.A. and Curry, N., 2022. Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial. Critical Care, 26(1), pp.1-12.
Wake, E., Ranse, J. and Marshall, A.P., 2022. Scoping review of the literature to ascertain how follow-up care is provided to major trauma patients post discharge from acute care. BMJ open, 12(9), p.e060902. http://dx.doi.org/10.1136/bmjopen-2022-060902
Wake, E., Atkins, H., Willock, A., Hawkes, A., Dawber, J. and Weir, K.A., 2022. Telehealth in trauma: A scoping review. Journal of Telemedicine and Telecare, 28(6), pp.412-422.
Ms Elizabeth Wake, A/Prof Shane George, Mrs Tash Adams, Dr Caitlin Brandenburg, Dr Clinton Gibbs, Dr Don Campbell, Dr Alistair Hamilton, Dr James Winearls
Associate Investigators: Dr John Casey, Dr Jack Righton, Ms Michelle Jeffress, Ms Paressa Cresswell, Dr Dan Bodnar
Major bleeding is a leading cause of death in trauma patients. Blood product replacement is a key component of damage control resuscitation aimed at limiting coagulopathy until definitive control of bleeding is achieved. Although Major Haemorrhage Protocols (MHP) are now widely used in the initial resuscitation of traumatically injured patients (1), protocols can vary based upon individual institutions' capabilities and processes. Within Australia, the National Blood Authority 2011 Patient Blood Management Guideline Module 1: Critical Care/ Massive Transfusion (2) recommended institutions develop standardized MHP to guide clinicians regarding the dose, timing and ratio of blood component therapy for bleeding trauma patients. However, it is currently unknown if these guidelines are implemented and if so, what institutional variations occur. While the guidelines provide a robust review of the evidence base for MHP, there is little information about the logistics of MHP implementation. Our project aims are firstly to compare the available trauma bleeding protocols across Queensland for content and quality. Secondly, we wish to understand the institution's capabilities of delivering an MHP in terms of the structure and processes available to them. Thirdly we want to explore the experiences of clinicians involved in delivering an MHP for trauma patients in both tertiary, rural and remote hospitals within Queensland. Expected benefits are to identify potential disparity of care for trauma patients in terms of MHP content, availability of resources and access to blood products. This information can help guide improvements in education, blood products availability and cost-effective care across Queensland.
